- Our Company
- News & Events
- Contact Us
Guardant360® CDx receiving FDA Approval is a landmark achievement for us. For advanced cancer patients in Asia, Middle East & Africa, this FDA approval lends even greater credibility to the test and its ability to provide comprehensive genomic profiling information that is critical to their cancer treatment. Click on the video to find out more:
View full press release at this link: https://lnkd.in/gwAmpCD
Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy. If you have any queries, send us an email at email@example.com or contact us on WhatsApp: +65 8940 0360.
Guardant360®. Test. Take Action.